Adalimumab (Humira) in combination with methotrexate has been shown to be effective for treating rheumatoid arthritis (RA) patients. Here are some pros and cons based on the knowledge base:

Pros
- Efficacy: The combination of adalimumab and methotrexate has demonstrated statistically significant improvements in ACR 20, Show Full Answer

Adalimumab (Humira) in combination with methotrexate has been shown to be effective for treating rheumatoid arthritis (RA) patients. Here are some pros and cons based on the knowledge base:

Pros:
- Efficacy: The combination of adalimumab and methotrexate has demonstrated statistically significant improvements in ACR 20, 50, and 70 responses compared to placebo and methotrexate alone.
- Improved Outcomes: Patients treated with this combination have shown better clinical outcomes in managing RA symptoms.

Cons:
- Cost: Biologic drugs like adalimumab are very expensive, and insurance approval is generally required.
- Adverse Reactions: Patients must be closely monitored for uncommon but serious adverse reactions, including:
- Infections from bacteria, viruses, and fungi
- Skin reactions and skin cancer (excluding melanoma)
- Allergic reactions
- Worsened heart failure
- Damage to nerves
- Low white blood cell count

Summary:
The combination of adalimumab and methotrexate is effective for RA treatment but comes with significant costs and potential risks that require careful monitoring.

 This AI-generated response comes from myRAteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Adalimumab (Humira) in Combination with Methotrexate is Efficacious for Treatment in RA Patients • Johns Hopkins Arthritis Center

Methotrexate Injections vs. Pills for RA: What To Know | myRAteam